Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals.
Cain LE, Caniglia EC, Phillips A, Olson A, Muga R, Pérez-Hoyos S, Abgrall S, Costagliola D, Rubio R, Jarrín I, Bucher H, Fehr J, van Sighem A, Reiss P, Dabis F, Vandenhende MA, Logan R, Robins J, Sterne JAC, Justice A, Tate J, Touloumi G, Paparizos V, Esteve A, Casabona J, Seng R, Meyer L, Jose S, Sabin C, Hernán MA; HIV-CAUSAL Collaboration.
Cain LE, et al. Among authors: caniglia ec.
Medicine (Baltimore). 2016 Oct;95(41):e5133. doi: 10.1097/MD.0000000000005133.
Medicine (Baltimore). 2016.
PMID: 27741139
Free PMC article.